Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine Dose Reduction vs Elimination with Rapamune in Renal Transplant
NCT00195468Phase 4Completed
- Sponsor
- Pfizer
- Start
- Mar 2004
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, open-label trial of sirolimus in kidney transplant rejection (2 arms), sponsored by Pfizer. Primary endpoint: Calculated Creatinine Clearance at 12 months. Started Mar 2004; status: completed.
02
Drugs
sirolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00195468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00195468.